IBOGF (Universal Ibogaine) Total Stockholders Equity: $0.20 Mil (As of Apr. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Universal Ibogaine Total Stockholders Equity?

Universal Ibogaine IBOGF +2.14% Total Stockholders Equity is $0.20 Mil as of Apr. 2025.

Universal Ibogaine's Total Stockholders Equity for the quarter that ended in Apr. 2025 was $0.20 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Universal Ibogaine's Book Value per Share for the quarter that ended in Apr. 2025 was $0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Universal Ibogaine's Debt-to-Equity for the quarter that ended in Apr. 2025 was 9.43.

Universal Ibogaine  (OTCPK:IBOGF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Universal Ibogaine's Book Value per Share for the quarter that ended in Apr. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(0.195-0)/308.611
=0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Universal Ibogaine's Debt-to-Equity for the quarter that ended in Apr. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.607 + 1.232) / 0.195
=9.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Total Stockholders Equity Related Terms

Universal Ibogaine Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Total Stockholders Equity Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Total Stockholders Equity
Get a 7-Day Free Trial 0.07 -0.00 3.05 1.33 0.72

Universal Ibogaine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.14 0.72 0.47 0.24 0.20
What does a Total Stockholders Equity of $0.20 Mil mean?
Universal Ibogaine (IBOGF) has a Total Stockholders Equity of $0.20 Mil as of Apr. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Universal Ibogaine and its competitors.
Is Universal Ibogaine's Total Stockholders Equity too high?
Universal Ibogaine's current Total Stockholders Equity is $0.20 Mil.
How does Universal Ibogaine's Total Stockholders Equity compare to LABT and CALC?
Universal Ibogaine's Total Stockholders Equity of $0.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Universal Ibogaine and its competitors. Universal Ibogaine's current Total Stockholders Equity is $0.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (IBOGF) has a current Total Stockholders Equity of $0.20 Mil. The current Total Stockholders Equity is $0.20 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current Total Stockholders Equity is $0.20 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.